Brief: China Regenerative Medicine obtains registration certificate for medical device Resunin
16/10/2015 15:50
Oct 16 (Reuters) - China Regenerative Medicine International Ltd 8158.HK : * Obtained the registration certificate for medical device for acellular anal fistula repair stroma * Says expectation associated with commercialisation of resunin may still take time to materalise * Source text for Eikon ID:nHKS3DPrQJ * ((For more news, please click here 8158.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital